Web Results



Sunitinib is an oral, small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor that was approved by the FDA for the treatment of renal cell ...

RCC | GIST | PNET | SUTENT® (sunitinib malate) Safety Info ...


SUTENT® (sunitinib malate) for treatment of advanced renal cell carcinoma, gastrointestinal stromal tumors & advanced pancreatic NET. Risk info for SUTENT®.

Sunitinib: MedlinePlus Drug Information


Aug 15, 2016 ... Sunitinib: learn about side effects, dosage, special precautions, and more on MedlinePlus.

Sunitinib Malate - National Cancer Institute


Oct 5, 2006 ... This page contains brief information about sunitinib malate and a collection of links to more information about the use of this drug, research ...

Sunitinib: Indications, Side Effects, Warnings - Drugs.com


Easy to read patient leaflet for sunitinib. Includes indications, proper use, special instructions, precautions, and possible side effects.

Sunitinib (Sutent®) - Cancer information - Macmillan Cancer Support


Find out more about sunitinib (also called Sutent®), which may be used to treat a type of kidney cancer called renal cell carcinoma (RCC), gastrointestinal ...

Sutent (Sunitinib Malate): Side Effects, Interactions, Warning ... - RxList


Learn about Sutent (Sunitinib Malate) may treat, uses, dosage, side effects, drug interactions, warnings, patient labeling, reviews, and related medications.

Sunitinib (Sutent®) | OncoLink


Jan 13, 2016 ... Sunitinib (Sutent®) is an oral multikinase inhibitor used in the treatment of some types of gastrointestinal stromal tumors, renal cell cancers and ...

Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma ...


Since sunitinib malate has shown activity in two uncontrolled studies in patients with metastatic renal-cell carcinoma, a comparison of the drug with interferon ...

Sunitinib: a multitargeted receptor tyrosine kinase inhibitor in the era ...


Sunitinib is an oral oxindole multitargeted kinase inhibitor that inhibits certain receptor tyrosine kinases (RTKs). These include vascular endothelial growth factor ...

More Info

Sunitinib - Chemotherapy Drugs - Chemocare


Trade Name: Sutent <sup>®</sup> Other Name: SU11248. Drug Type: Sunitinib is a targeted therapy and is a receptor protein-tyrosine kinase inhibitor. It inhibits the actions ...

Sunitinib (Sutent) | Cancer Research UK


May 12, 2015 ... Read about the cancer treatment drug sunitinib, otherwise known as Sutent, including what it is, how it works and possible side effects.

Definition of sunitinib malate - NCI Drug Dictionary - National ...


sunitinib malate: Patient Information: The orally bioavailable malate salt of an indolinone-based tyrosine kinase inhibitor with potential antineoplastic activity.